Royal Society of Chemistry, Inorganic Chemistry Frontiers, 13(9), p. 3295-3305, 2022
DOI: 10.1039/d2qi00778a
Full text: Unavailable
New compounds structurally derived from oxaliplatin exhibit high potency in malignant pancreatic adenocarcinoma cells. Their mechanism of antiproliferative action in pancreatic cancer cells involves inhibition of de novo lipid synthesis.